Global Intravenous Solutions Sales Report Thumbnail

Global Intravenous Solutions Sales Market by Type (Crystalloids, Colloids, Others), By Application (Basic IV Solutions, Nutrient Infusion Solution, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-61192
  • Author: Up Market Research
  • Rating: 4.7
  • Total Reviews: 69
  • No. Of Pages: 248
  • Format:
  • Pub. Date: 2021-04-04
  • Share:

The Global Intravenous Solutions Market size was valued at USD 11.4 billion in 2018 and is expected to reach USD 13.8 billion by 2028, growing at a CAGR of 3.6% from 2021-2028. The growth can be attributed to the rising number of chronic diseases such as diabetes mellitus type II that are increasing the demand for IV solutions globally which in turn is driving the growth of this market during the forecast period 2021-2028.

 

Intravenous Solutions are liquids that medication and other substances can be dissolved in, to deliver them intravenously. They put the fluid directly into a vein through a needle or catheter. Intravenous solutions are used for medications such as chemotherapy drugs, which cannot be taken orally because they are not absorbed well by the intestinal lining (the stomach mucosa).

 

On the basis of Types, the market is segmented into Crystalloids, Colloids, and Others.

 

Crystalloids:

Crystalloids are a type of fluid solution that contains salts and other minerals. They help balance the body's fluids by adding electrolytes, which may be lost during illness or injury. In most cases, doctors prescribe crystalloid solutions for patients who've undergone surgery to replace cells and blood vessels in their bodies with plastic substitutes.

 

Colloids:

Colloids are a type of IV solution that is administered intravenously and can be classified as either synthetic or natural. Synthetic colloids, such as Albumin and Dextran, have a smaller molecular size than blood plasma proteins while Natural Colloid sources like Gelatin Powder have the same motional properties in liquid form. The latter requires more processing before it can be used for infusion purposes because gelatin contains high amounts of denatured protein chains which need to be broken down by heating and cooling.

 

On the basis of Application, the market is segmented into Basic IV Solutions, Nutrient Infusion Solution, and Others. The Basic IV Solutions segment accounted for the largest share of global revenues due to its extensive use in hospitals.

 

Basic IV Solutions:

Intravenous Solutions are used as a supplement while intravenously providing fluids, nutrition, and medications in the form of IV bags. Intravenous solutions may also be given to patients who cannot swallow their food or medication for any reason. The application is primarily used by physicians, nurses, and other healthcare personnel when they need to administer large doses of prescribed medicines with minimal risk of side effects or complications from oral administration.

 

Nutrient Infusion Solution:

Intravenous Solutions are used as a nutrient therapy to provide the body with essential minerals, vitamins, and nutrients. Nutrient infusions are an alternative way to deliver nutrition by combining different types of Intravenous Solutions such as glucose solution (crystalloids), amino acid solution (colloid), and lipid emulsion.

 

On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is projected to witness unparalleled growth on account of the increasing life expectancy rates as well as the rising expenditure by patients and governments. The Asia Pacific market is projected to witness significant growth on account of the changing economic environment in developing countries such as India and China.

 

Growth Factors For The Global Intravenous Solutions Market:

The major growth drivers for this market are an increase in government initiatives, advancements in technology, increasing incidence of chronic disease such as diabetes mellitus and cancer, rising prevalence of infectious diseases including HIV/AIDS which leads to increased use of intravenous fluids (IV) during illness treatment among others.

 


Up Market Research published a new report titled “Intravenous Solutions Sales Market research report which is segmented by Types (Crystalloids, Colloids, Others), By Applications (Basic IV Solutions, Nutrient Infusion Solution, Others), By Players/Companies Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, Fresenius Kabi, JW Life Science, B. Braun Melsungen”. 

 

Report Scope

Report Attributes Report Details
Report Title Intravenous Solutions Sales Market Research Report
By Type Crystalloids, Colloids, Others
By Application Basic IV Solutions, Nutrient Infusion Solution, Others
By Companies Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, Fresenius Kabi, JW Life Science, B. Braun Melsungen
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 248
Number of Tables & Figures 174
Customization Available Yes, the report can be customized as per your need.
 

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Intravenous Solutions Sales Industry Outlook
 

Global Intravenous Solutions Sales Market Report Segments:

The market is segmented by Type Crystalloids, Colloids, Others and By Application Basic IV Solutions, Nutrient Infusion Solution, Others.

 

Some of the companies that are profiled in this report are:

  1. Baxter
  2. Kelun Group
  3. Fresenius Kabi
  4. Otsuka
  5. ICU Medical
  6. Fresenius Kabi
  7. JW Life Science
  8. B. Braun Melsungen
 

Intravenous Solutions Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

 

Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Intravenous Solutions Sales Market
 

Overview of the regional outlook of the Intravenous Solutions Sales Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Intravenous Solutions Sales Market Overview
 

Highlights of The Intravenous Solutions Sales Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Intravenous Solutions Sales Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Crystalloids

                2. Colloids

                3. Others

       7. By Application:

                1. Basic IV Solutions

                2. Nutrient Infusion Solution

                3. Others

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.
 

We have studied the Intravenous Solutions Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

 

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Intravenous Solutions Sales Market Statistics
 

Reasons to Purchase the Intravenous Solutions Sales Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intravenous Solutions Sales Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Intravenous Solutions Sales Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Intravenous Solutions Sales Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Intravenous Solutions Sales Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Intravenous Solutions Sales Market Size & Forecast, 2018-2028 
      4.5.1 Intravenous Solutions Sales Market Size and Y-o-Y Growth 
      4.5.2 Intravenous Solutions Sales Market Absolute $ Opportunity 


Chapter 5 Global Intravenous Solutions Sales Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Intravenous Solutions Sales Market Size Forecast by Type
      5.2.1 Crystalloids
      5.2.2 Colloids
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Intravenous Solutions Sales Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Intravenous Solutions Sales Market Size Forecast by Applications
      6.2.1 Basic IV Solutions
      6.2.2 Nutrient Infusion Solution
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Intravenous Solutions Sales Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Intravenous Solutions Sales Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Intravenous Solutions Sales Analysis and Forecast
   9.1 Introduction
   9.2 North America Intravenous Solutions Sales Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Intravenous Solutions Sales Market Size Forecast by Type
      9.6.1 Crystalloids
      9.6.2 Colloids
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Intravenous Solutions Sales Market Size Forecast by Applications
      9.10.1 Basic IV Solutions
      9.10.2 Nutrient Infusion Solution
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Intravenous Solutions Sales Analysis and Forecast
   10.1 Introduction
   10.2 Europe Intravenous Solutions Sales Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Intravenous Solutions Sales Market Size Forecast by Type
      10.6.1 Crystalloids
      10.6.2 Colloids
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Intravenous Solutions Sales Market Size Forecast by Applications
      10.10.1 Basic IV Solutions
      10.10.2 Nutrient Infusion Solution
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Intravenous Solutions Sales Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Intravenous Solutions Sales Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Intravenous Solutions Sales Market Size Forecast by Type
      11.6.1 Crystalloids
      11.6.2 Colloids
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Intravenous Solutions Sales Market Size Forecast by Applications
      11.10.1 Basic IV Solutions
      11.10.2 Nutrient Infusion Solution
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Intravenous Solutions Sales Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Intravenous Solutions Sales Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Intravenous Solutions Sales Market Size Forecast by Type
      12.6.1 Crystalloids
      12.6.2 Colloids
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Intravenous Solutions Sales Market Size Forecast by Applications
      12.10.1 Basic IV Solutions
      12.10.2 Nutrient Infusion Solution
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Intravenous Solutions Sales Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Intravenous Solutions Sales Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Intravenous Solutions Sales Market Size Forecast by Type
      13.6.1 Crystalloids
      13.6.2 Colloids
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Intravenous Solutions Sales Market Size Forecast by Applications
      13.10.1 Basic IV Solutions
      13.10.2 Nutrient Infusion Solution
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Intravenous Solutions Sales Market: Competitive Dashboard
   14.2 Global Intravenous Solutions Sales Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Baxter
      14.3.2 Kelun Group
      14.3.3 Fresenius Kabi
      14.3.4 Otsuka
      14.3.5 ICU Medical
      14.3.6 Fresenius Kabi
      14.3.7 JW Life Science
      14.3.8 B. Braun Melsungen
Segments Covered in the Report
The global Intravenous Solutions Sales market has been segmented based on

By Types
  • Crystalloids
  • Colloids
  • Others
By Applications
  • Basic IV Solutions
  • Nutrient Infusion Solution
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • Otsuka
  • ICU Medical
  • Fresenius Kabi
  • JW Life Science
  • B. Braun Melsungen

Buy Report